Physician profile
Robert A Catania
NPI 1679534713
$8,522.42
in general payments reported to CMS, 2019-2025
12 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $546 · 2020: $414 · 2021: $322 · 2022: $4,657 · 2023: $229 · 2024: $1,962 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,381 · Travel and Lodging: $1,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,381.06 |
| Travel and Lodging | $1,202.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,102.25 | 2019-2024 | Da Vinci Surgical System |
| Enterra Medical, INC. | $1,927.91 | 2024-2025 | |
| Davol INC. | $531.49 | 2022-2025 | Phasix Mesh |
| Medtronic, INC. | $361.02 | 2021-2023 | |
| Novo Nordisk INC | $175.86 | 2019-2025 | Wegovy |
| W. L. Gore & Associates, INC. | $172.57 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Endogastric Solutions, INC | $112.12 | 2019 | |
| Mesh Suture INC | $39.02 | 2025 | |
| Conmed Corporation | $29.42 | 2023 | Airseal |
| Olympus America INC. | $24.18 | 2024 | |
| Covidien LP | $23.35 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $23.23 | 2023 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Catania listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.